T1	Pharmacological_substance 94 104	interferon
N1000 	Reference T1 MeSH:D007372	interferon
T2	Pharmacological_substance 492 513	peginterferon alfa-2a
N1001 	Reference T2 MeSH:C100416	peginterferon alfa-2a
T4	Pharmacological_substance 518 527	ribavirin
N1002 	Reference T4 MeSH:D012254	ribavirin
T5	Disorder 532 561	chronic hepatitis C infection
N1 	Reference T5 UMLS:C0524910	chronic hepatitis C infection
T6	Pharmacological_substance 626 634	Artecoll
N1003 	Reference T6 MeSH:C445359	Artecoll
T7	Pharmacological_substance 715 726	allopurinol
N1004 	Reference T7 MeSH:D000493	allopurinol
T8	Pharmacological_substance 1018 1028	Interferon
N1005 	Reference T8 MeSH:D007372	Interferon
T9	Disorder 1127 1147	chronic inflammation
N2 	Reference T9 UMLS:C0021376	chronic inflammation
T10	Pharmacological_substance 1173 1183	interferon
N1006 	Reference T10 MeSH:D007372	interferon
T11	Disorder 1194 1205	sarcoidosis
N3 	Reference T11 UMLS:C0036202	sarcoidosis
T12	Pharmacological_substance 344 360	immunomodulatory
N1007 	Reference T12 MeSH:D007155	immunomodulatory
T13	Subject 386 403	48-year-old woman
T14	Disorder 431 443	facial edema
N4 	Reference T14 UMLS:C0542571	facial edema
T17	Pharmacological_substance 666 688	polymethylmethacrylate
N1008 	Reference T17 MeSH:D019904	polymethylmethacrylate
T18	Pharmacological_substance 1033 1068	other immunostimulatory medications
T20	Pharmacological_substance 1343 1353	interferon
N1009 	Reference T20 MeSH:D007372	interferon
T23	Disorder 994 1016	granulomatous reaction
